Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Type II ROS1 Inhibition Overcomes Type I Inhibitor Resistance in ROS1 Fusion–Positive Lung Cancers: A Phase II Trial of Cabozantinib. Local targets link to admitted publications; unresolved targets remain external evidence.
